Overall Survival in Elderly Metastatic Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade

被引：0
|
作者：
Simoes, M. F. [1 ]
Medeiros, M. F. [1 ]
Maciel Santana, D. [1 ]
De Andrade Souza, C. I. [1 ]
Mendes Gomes, L. B. [1 ]
De Freitas, H. [1 ]
Petrocchi Corassa, M. [1 ]
Spina Donadio, M. D. [1 ]
De Lima, V. C. [1 ]
机构：
[1] AC Camargo Canc Ctr, Clin Oncol, Antonio Prudente, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immunotherapy; Metastatic non-small cell lung cancer; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P09.09
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [21] Peripheral immune kinetics in survival prediction of small cell lung cancer patients treated with immune checkpoint blockade therapy
    Galindo Campos, M. A.
    Hardy-Werbin, M.
    Gibert, J.
    Rios-Hoyo, A.
    Rossell, A.
    Gonzalez, S.
    Rocha, P.
    Del Rey-Vergara, R.
    Rovira, A.
    Arriola, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S191 - S191
  • [22] The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    Oh, Michael
    Oh, Michael
    Guzner, Alex
    Wainwright, Derek
    Mohindra, Nisha
    Chae, Young Kwang
    Behdad, Amir
    Villaflor, Victoria
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [23] Association of Opioid Use with Survival in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitor Therapy
    Mock, J.
    Wynter, E.
    Young, P.
    Sytov, A.
    Elghawy, O.
    Gentzler, R.
    Novicoff, W.
    Martin, L.
    Hall, R.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S20 - S21
  • [24] RAMUCIRUMAB PLUS ATEZOLIZUMAB IN PATIENTS WITH STAGE IV NON-SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH IMMUNE CHECKPOINT BLOCKADE
    Herzog, Brett
    Waqar, Saiama
    Devarakonda, Siddhartha
    Ward, Jeffrey
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A480 - A480
  • [25] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [26] Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Guo, Matthew Z.
    Balaji, Aanika
    Murray, Joseph C.
    Reuss, Joshua E.
    Steinke, Seema Mehta
    Bennett, Kathleen
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2023, 24 (07) : 613 - 620
  • [27] Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer
    Hallqvist, Andreas
    Rohlin, Anna
    Raghavan, Sukanya
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2020, 92 (06)
  • [28] Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
    Liu, Xiaoming
    Cho, William C.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [29] Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer
    Yang, Jiali
    Chen, Juan
    Wei, Jun
    Liu, Xiaoming
    Cho, William C.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (10) : 1209 - 1223
  • [30] Immune checkpoint inhibitors in non-small cell lung cancer: is simultaneous blockade better?
    Eubanks, Jennifer T.
    Ramalingam, Suresh S.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S532 - S535
12345